North America (change)      
Cognos

Cognos Home > News Highlights > 2001 News Releases > News Release
Cognos® Reports Strong Third Quarter Earnings

- Delivers 17 Percent Sequential Growth in Business Intelligence License Revenue -

OTTAWA, December 20, 2001—Cognos Incorporated (Nasdaq: COGN; TSE: CSN), the world leader in business intelligence solutions, today announced results for its third quarter of fiscal year 2002, which ended November 30, 2001.

Revenue for the quarter was $124.2 million, compared with revenue of $124.6 million for the same period last year and up from revenue of $116.3 million in the second quarter of this year. Net income was $13.3 million or $0.15 per share. This compares with net income of $13.6 million or $0.15 per share in the third quarter of last year. Excluding a write-off of $3.0 million for acquired in-process technology associated with an acquisition, net income for the same period last year was $16.6 million or $0.18 per share.

Revenue for the nine-month period ended November 30, 2001 was $348.5 million, compared with revenue of $351.5 million for the first nine months of last year. Net income for the first nine months of this year, including restructuring charges of $12.8 million, was $9.3 million or $0.10 per share. Excluding restructuring charges, net income for the first nine months of this year was $18.3 million or $0.20 per share. This compares with net income of $42.1 million or $0.46 per share in the first nine months of last year. Excluding a write-off of $3.0 million for acquired in-process technology, net income for the first nine months of last year was $45.1 million or $0.49 per share. All figures are stated in U.S. dollars.

Business intelligence (BI) license revenue increased by 17 percent from the second quarter of this year, continuing its strong momentum. BI license revenue was $56.5 million, compared with $61.8 million for the same period last year. Total BI revenue increased by 7 percent from the previous quarter of this year to reach $114.1 million in the quarter. This compares to $112.8 million in the third quarter of last year.

Cognos continued to strengthen its balance sheet during the quarter. Cash flow was $10.0 million, net of $10.0 million expended to repurchase stock in the quarter. The Company had $268.1 million in cash, cash equivalents, and short-term investments at the end of the third quarter.

"We are pleased with the results for the third quarter, particularly given the current economic conditions" said Ron Zambonini, Cognos President and CEO. "We continue to assert our leadership in the BI market by driving the best momentum, as demonstrated by the strong sequential growth in total BI revenue and BI license revenue again this quarter.

"Major organizations throughout the world made significant commitments to our enterprise business intelligence solution. The Company was awarded six contracts greater than $1 million in the quarter, demonstrating the continued advancement of BI in enterprise deployments encompassing intranets and extranets alike. The contracts represented a diversity of industries from leading organizations such as Amgen, the world's largest independent biotechnology company; Mattel, the world's largest toy company; the U.S. Air Force, which uses our software to optimize its supply and maintenance systems for its fleet of aircraft; Metropolitan Life Insurance, in a large extranet deployment to reach its diverse corporate client base; and ePeopleServe, a new Cognos partner, and a joint venture between British Telecom and Anderson Consulting to provide extranet-based human resources services.

"We are entering the strongest product cycle in the history of the Company," continued Mr. Zambonini. "Cognos Series 7 has completed a highly successful beta phase and will ship in January 2002. We continue to receive extremely positive feedback from our beta customers and from more than 8,000 Cognos customers who had a close look at Series 7 at our global user events throughout the third quarter. They clearly see the value of a fully integrated, comprehensive, and highly scalable BI solution. And we are significantly broadening our analytic applications product family. In addition to our new planning module for Cognos Finance, we are introducing a full suite of applications for Oracle environments in this fourth quarter, and for SAP early next fiscal year. Cognos is the only vendor to deliver true enterprise business intelligence encompassing the entire enterprise decision cycle — planning & budgeting, reporting, analysis, and mission control — in other words, enterprise-wide business performance management."

This press release contains forward-looking statements relating to, among other things, the Company's expectations concerning the success and soundness of the Company's business model and its sales, marketing and technology strategies; the effect of the continuing uncertain economic environment on those strategies; the Company's ability to deliver business intelligence solutions that respond to changing market requirements; the updating, development, qualification, introduction, and shipment of the Company's current and future products; and the Company's ability to compete in an intensely competitive market.

These forward-looking statements are neither promises nor guarantees, but involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Factors that may cause such differences include, but are not limited to: the Company's ability to develop and introduce new products and enhancements in the business intelligence software market; the impact of global economic conditions on the Company's business and the Company's ability to implement timely and appropriate remedial measures; the Company's ability to select and implement appropriate business models and strategies; the Company's ability to maintain revenue growth or to anticipate a decline in revenue from any of its products or services; fluctuations in its quarterly and annual operating results based on historical patterns, which may cause its stock price to fluctuate or decline; rapid technological change in the business intelligence software market; new product introductions and enhancements by competitors; the Company's ability to compete in an intensely competitive market; the Company's reliance on partners and other third party distribution channels to market and distribute its products; unauthorized use of the Company's intellectual property; claims by third parties that its software infringes their intellectual property; the risks inherent in international operations, such as currency exchange rate fluctuations; the Company's ability to identify, hire, train, motivate and retain highly qualified management and other key personnel; and the Company's ability to identify, pursue and complete acquisitions which could divert management attention and financial resources and not produce desired business results; as well as the risk factors discussed in the Company's most recent Annual Report on Form 10-K filed with the United States Securities and Exchange Commission. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statement to reflect any change in its expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

Cognos will present the Company's financial results for the third quarter fiscal year 2002 and discuss expectations for the future at 5:15 p.m. Eastern Time, today, December 20, 2001. The conference call may be accessed at 416-646-3095. The Webcast may be accessed at http://www.cognos.com/company/investor/events/fy02q3/index.html.

###

Cognos and the Cognos logo are trademarks or registered trademarks in the United States and/or other countries.


COGNOS INCORPORATED
CONSOLIDATED STATEMENTS OF INCOME

(US$000s except share amounts, U.S. GAAP)
(Unaudited)


 

Three Months Ended
November 30,
Nine Months Ended
November 30,

 

2001    2000  2001    2000 

Revenue
   Product license $ 59,114   $ 64,832  $ 152,835   $183,050 
   Product support 44,578   37,635  129,005   106,610 
   Services 20,489   22,171  66,670   61,889 

Total revenue 124,181   124,638  348,510   351,549 

Operating expenses
   Cost of product license 847   1,925  2,915   5,367 
   Cost of product support 3,825   4,551  11,981   12,896 
   Selling, general, and administrative 84,943   81,339  259,127   229,895 
   Research and development 17,579   16,854  55,424   49,215 
   Acquired in-process technology —   3,000  —   3,000 
   Restructuring —   —  12,798   — 

Total operating expenses 107,194   107,669  342,245   300,373 

Operating income 16,987   16,969  6,265   51,176 
Interest expense (88) (230) (257) (540)
Interest income 1,947   3,355  7,167   9,034 

Income before taxes 18,846   20,094  13,175   59,670 
Income tax provision 5,560   6,467  3,887   17,548 

Net income $ 13,286   $ 13,627  $  9,288   $ 42,122 

Net income per share
   Basic $0.15   $0.15  $0.11   $0.48 

   Diluted $0.15   $0.15  $0.10   $0.46 

Weighted average number of shares (000s)
   Basic 87,488   88,249  87,840   87,647 

   Diluted 89,456   92,646  89,980   92,170 


COGNOS INCORPORATED
CONSOLIDATED BALANCE SHEETS

(US$000s, U.S. GAAP)

  November 30, 
2001 
February 28, 
2001 

Assets (Unaudited)  
Current assets 
  Cash and cash equivalents $154,236   $115,293 
  Short-term investments 113,881   119,265 
  Accounts receivable 100,130   146,867 
  Inventories 518   730 
  Prepaid expenses 6,566   8,648 
  Income tax assets 5,525   — 

  380,856   390,803 
Fixed assets 65,127   74,208 
Other assets 23,322   30,581 

  $469,305   $495,592 

Liabilities
Current liabilities
  Accounts payable $ 23,980   $ 28,256 
  Accrued charges 31,349   21,798 
  Salaries, commissions, and related items 34,447   28,822 
  Income taxes payable 672   17,548 
  Current portion of long-term debt 32   32 
  Deferred revenue 85,003   96,674 

  175,483   193,130 
Long-term liabilities 766   1,539 
Deferred income taxes 7,931   10,394 

  184,180   205,063 

Stockholders’ Equity
Capital stock
  Common shares
        (November 30, 2001 - 87,277,837;
        February 28, 2001 - 87,885,161)
141,484   134,791 
Retained earnings 157,089   165,755 
Accumulated other comprehensive items (13,448) (10,017)

  285,125   290,529 

  $469,305   $495,592 


COGNOS INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS

(US$000s, U.S. GAAP)
(Unaudited)


  Three Months Ended
November 30,
Nine Months Ended
November 30,
  2001  2000  2001  2000 

Cash provided by (used in) operating activities
   Net income $ 13,286   $ 13,627  $  9,288   $ 42,122 
   Non-cash items
      Depreciation and amortization 8,053   6,107  22,581   16,455 
      Amortization of deferred stock-based compensation 504   173  1,658   519 
      Amortization of other deferred compensation 606   345  1,938   1,035 
      Write-off of acquired in-process technology —   3,000  —   3,000 
      Deferred income taxes (309)  1,898  (2,127)  1,916 
      Loss on disposal of fixed assets 43   583   215 

  22,183   25,152  33,921   65,262 
Change in non-cash working capital
   Decrease (increase) in accounts receivable (6,116)  (23,765) 51,080   (25,579)
   Decrease (increase) in inventory 48   (77) 192   (58)
   Decrease (increase) in prepaid expenses 366   256  1,911   (1,667)
   Decrease (increase) in income tax assets 2,768   —  (5,526)  — 
   Increase (decrease) in accounts payable (1,631)  3,297  (10,045)  3,131 
   Increase in accrued charges 3,911   1,660  9,989   5,993 
   Increase in salaries, commissions, and related items 3,410   3,380  5,944   1,736 
   Increase (decrease) in income taxes payable (144)  918  (16,747)  3,607 
   Increase (decrease) in deferred revenue (2,123)  176  (10,693)  (559)

  22,672   10,997  60,026   51,866 

Cash provided by (used in) investing activities
   Maturity of short-term investments 56,557   47,249  236,788   139,069 
   Purchase of short-term investments (83,144)  (117,608) (232,035)  (193,207)
   Additions to fixed assets (2,026)  (16,404) (10,401)  (42,998)
   Acquisition costs —   (10,406) —   (11,260)

  (28,613)  (97,169) (5,648)  (108,396)

Cash provided by (used in) financing activities
   Issue of common shares 1,645   4,136  7,073   20,014 
   Repurchase of shares (9,994)  —  (19,992)  (2,053)
   Repayment of long-term debt and long-term liabilities (806)  (2,800) (645)  (2,414)

  (9,155)  1,336  (13,564)  15,547 

Effect of exchange rate changes on cash (977)  (846) (1,871)  (1,598)

Net increase (decrease) in cash and cash equivalents (16,073)  (85,682) 38,943   (42,581)
Cash and cash equivalents, beginning of period 170,309   175,536  115,293   132,435 

Cash and cash equivalents, end of period 154,236   89,854  154,236   89,854 
Short-term investments, end of period 113,881   116,534  113,881   116,534 

Cash, cash equivalents, and short-term investments,end of period $268,117   $206,388  $268,117   $206,388 


Note to Editors:
Copies of previous Cognos press releases and Corporate and product information are available on Cognos' Web site at http://www.cognos.com, and at PR Newswire's site at http://www.prnewswire.com.

In The News